Cinctive Capital Management LP Exact Sciences Corp Call Options Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $1.6 Million - $2.47 Million
-50,000 Reduced 71.43%
20,000 $650,000
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $1.42 Million - $3.05 Million
40,000 Added 133.33%
70,000 $2.76 Million
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $725,000 - $1.01 Million
10,000 Added 50.0%
30,000 $2.34 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $1.8 Million - $2.48 Million
20,000 New
20,000 $1.91 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email